Cargando…
PBK/TOPK overexpression and survival in solid tumors: A PRISMA-compliant meta-analysis
BACKGROUND: The prognostic significance of PBK/TOPK overexpression in solid tumors remains controversial. Therefore, we carried out a meta-analysis to evaluate the impact of PBK/TOPK overexpression in solid tumors on patients’ overall survival (OS) and disease-free survival (DFS). METHODS: Relevant...
Autores principales: | Xu, Ming, Xu, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417550/ https://www.ncbi.nlm.nih.gov/pubmed/30855480 http://dx.doi.org/10.1097/MD.0000000000014766 |
Ejemplares similares
-
PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas
por: Zhu, Kejing, et al.
Publicado: (2022) -
PBK/TOPK Expression Predicts Prognosis in Oral Cancer
por: Chang, Chin-Fang, et al.
Publicado: (2016) -
Overexpression of PBK/TOPK relates to poor prognosis of patients with breast cancer: a retrospective analysis
por: Qiao, Liang, et al.
Publicado: (2022) -
PBK/TOPK: A Therapeutic Target Worthy of Attention
por: Han, Ziping, et al.
Publicado: (2021) -
Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma
por: Ohashi, Takuma, et al.
Publicado: (2017)